Ушбу иш иқтибос қилган ишлар

163 та иш

Иш: Translational research of new developments in targeted therapy of colorectal cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram +3
Мақола201834 иқтибос
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Мақола20109 иқтибос
ABI
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth
Шарҳ мақола20115 иқтибос
ABI
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Шарҳ мақола20205 иқтибос
ABI
Сарлавҳасиз
Бошқа4 иқтибос
ABI
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny +12
Мақола20044 иқтибос
ABI
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13
Мақола20064 иқтибос
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Шарҳ мақола20214 иқтибос
ABI
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Rakesh K. Jain
Шарҳ мақола20013 иқтибос
ABI
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Шарҳ мақола20183 иқтибос
ABI
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22
Мақола20153 иқтибос
ABI
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey, Eric Van Cutsem, Alberto Sobrero +17
Мақола20123 иқтибос
ABI
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong +17
Мақола20183 иқтибос
ABI
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong +8
Шарҳ мақола20213 иқтибос
ABI
Strategies for enzyme/prodrug cancer therapy.
Guo Xu, Howard L. McLeod
Мақола20012 иқтибос
ABI
An overview of targeted cancer therapy
V. Vijaya Padma
Мақола20152 иқтибос
ABI
Сарлавҳасиз
Бошқа2 иқтибос
ABI
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Simon Dagenais, Leo Russo, Ann Madsen +2
Шарҳ мақола20212 иқтибос
ABI
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Rakesh K. Jain
Шарҳ мақола20052 иқтибос
ABI
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata +11
Мақола20132 иқтибос
ABI
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10
Шарҳ мақола20152 иқтибос
ABI
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady +25
Мақола20142 иқтибос
ABI
Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung, Ira Gore, Lawrence Fong +8
Мақола20102 иқтибос
ABI
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Leonard B. Saltz, John V. Cox, Charles D. Blanke +9
Мақола20002 иқтибос
ABI
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman, Ray McDermott, Joseph L. Leach +13
Мақола20172 иқтибос
ABI